MORE

(redirected from Multiple Outcomes of Raloxifene Evaluation)
Also found in: Dictionary, Thesaurus, Legal, Encyclopedia.

MORE

Abbreviation for:
Multiple Outcomes of Raloxifene Evaluation

MORE

Osteoporosis A clinical trial–Multiple Outcomes of Raloxifene Evaluation–that evaluated the effect of raloxifene on ↓ fracture risk in ♀, and the secondary impact of raloxifene therapy on ♀ cancer. See Osteoporosis, Raloxifene.
Mentioned in ?
References in periodicals archive ?
Interest in the drug's cardioprotective potential was sparked in large part by a posthoc analysis of the landmark Multiple Outcomes of Raloxifene Evaluation (MORE) trial, which showed a 40% reduction in events with raloxifene, compared with placebo, in participants at increased cardiovascular risk.
Lilly's Multiple Outcomes of Raloxifene Evaluation (MORE) -- a study involving 7,705 postmenopausal women with osteoporosis -- reached its planned objectives in 1999.
In addressing the role of SERMs in osteoporosis, Dr Lindsay focused on data from a study of the SERM raloxifene, the Multiple Outcomes of Raloxifene Evaluation (MORE) trial.
Multiple outcomes of raloxifene evaluation (erratum in: Breast Cancer Res Treat 2001;67:191).
These findings from the Multiple Outcomes of Raloxifene Evaluation (MORE) study, sponsored by Eli Lilly and Company (NYSE: LLY), were reported today at the American College of Rheumatology meeting in Philadelphia by lead investigator Michael Maricic, M.

Full browser ?